CG Results Healthcare advises Sovereign Capital Partners on its investment in Bioscript
- Service: M&A
- Sector: Healthcare
- Sub Sector: Pharma Commercialisation Services
- Engagement Type: Buy Side
CG Results Healthcare is delighted to announce that it has advised leading UK private equity firm Sovereign Capital Partners on its significant investment in Bioscript, an independent medical communications agency serving international pharmaceutical, biotechnology and medical device companies.
Established in 2005, Bioscript is an international provider of medical communications and regulatory writing services for pharmaceutical companies. Headquartered in the UK and with a team of almost 100, Bioscript assists clients in their communications with regulatory authorities as well as educating the medical sector on pharmaceutical products that are in mid to late-stage clinical trials and subsequently supporting these products, post-market launch, to maintain and grow sales throughout the lifecycle of the drug.
This transaction highlights the value of CG Results Healthcare’s sector knowledge to private equity bidders and cements the firm’s expertise in the healthcare communications sector, following deals including the sale of Cormis Partners to Huntsworth, Unlimited Health’s US division to Next15 and 2e Creative to Fishawack.
CG Results Healthcare are highly regarded for their sector knowledge in medical communications – it was a pleasure to work with them on our investment in Bioscript
Managing Partner, Sovereign Capital Partners